CA ATC C08DB01 · updated 4 Nov 2026
Diltiazem shortage in Canada
Is there a Diltiazem shortage in Canada?
Yes. As of 4 Nov 2026, 23 Diltiazem products are reported short in Canada, the first since 10 Mar 2017. The company estimate for the return is 6 Nov 2026 (latest 31 May 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Belgium, Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-DILTIAZ SR - 90MG/SRC (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ SR - SRC 120MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ SR - SRC 60MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DILTIAZEM (100) | TEVA CANADA LIMITED | 1 Mar 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT DILTIAZEM CD (100) | TEVA CANADA LIMITED | 1 Dec 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP DILTIAZEM CD (100) | JAMP PHARMA CORPORATION | 12 Mar 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 17 Mar 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 31 Mar 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP DILTIAZEM CD (Bottle 100) | JAMP PHARMA CORPORATION | 21 Apr 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM HYDROCHLORIDE INJECTION (10 x 5 mL vial / fiole) | OMEGA LABORATORIES LIMITED | 1 May 2026 | 31 Mar 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SIVEM PHARMACEUTICALS ULC | 6 Jun 2026 | 1 May 2027 | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 9 Jun 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-DILTIAZEM CD (100) | TEVA CANADA LIMITED | 10 Jun 2026 | 10 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SIVEM PHARMACEUTICALS ULC | 15 Jun 2026 | 1 May 2027 | Manufacturing problem Requirements related to complying with good manufacturing practices |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 3 Aug 2026 | 15 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SANIS HEALTH INC | 5 Aug 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DILTIAZ CD (100 BTL) | APOTEX INC | 25 Aug 2026 | 31 May 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 27 Aug 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 28 Aug 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PRO-DILTIAZEM CD (100) | PRO DOC LIMITEE | 8 Sep 2026 | 15 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DILTIAZEM CD (100) | SANIS HEALTH INC | 5 Oct 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | M-DILTIAZEM CD (Bottle of 100 tablets) | MANTRA PHARMA INC | 19 Oct 2026 | 15 Dec 2026 | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-DILTIAZEM CD (BOTTLE X 100 CAPS) | MARCAN PHARMACEUTICALS INC | 20 Oct 2026 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.